Keiko Taguchi
12PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Dec 24, 2024
Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma.Hiroyuki Oshikiri, Keiko Taguchi, Wataru Hirose
|Jan 25, 2024
Whole blood transcriptome analysis for age- and gender-specific gene expression profiling in Japanese individuals.Yu-Ichi Aoki, Keiko Taguchi, Hayato Anzawa
|Oct 19, 2023
Sulforaphane decreases serum selenoprotein P levels through enhancement of lysosomal degradation independent of Nrf2.Xinying Ye, Takashi Toyama, Keiko Taguchi
|Oct 14, 2022
The KEAP1-NRF2 System and Esophageal Cancer.Wataru Hirose, Hiroyuki Oshikiri, Keiko Taguchi
|Sep 20, 2022
Construction of a trio-based structural variation panel utilizing activated T lymphocytes and long-read sequencing technology.Akihito Otsuki, Yasunobu Okamura, Noriko Ishida
|Jun 08, 2022
The β-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation <i>In Vivo</i>.Ayumi Kuga, Kouhei Tsuchida, Harit Panda
Pageof 2
Frequent Collaborators
7 joint publications
Masayuki Yamamoto
3 joint publications
Fumiki Katsuoka
2 joint publications
Thomas W Kensler
2 joint publications
Mikiko Suzuki
2 joint publications
Akihito Otsuki
2 joint publications
Hiroyuki Oshikiri
1 joint publications
Akira Uruno
1 joint publications
Takafumi Suzuki
1 joint publications
Norio Suzuki
1 joint publications
Ritsuko Shimizu
